Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: Final long-term results

Eugene Schiff, Cjing Lung Lai, Stephanos Hadziyannis, Peter Nuehaus, Norah Terrault, Massimo Colombo, Hans Tillmann, Didler Samuel, Stefan Zuezem, Jean Pierre Villenueve, Sarah Arteburn, Katyna Borroto-Esoda, Carol Brosgart, Steven Chuck, Ahmad Obaid Shakil, Jhon Fung, Alfredo Alberti, Anna Lok, Antonio Picciotto, Francesco TorreCaroline Riely, Christian Trepo, Thierry Bizollon, Danielle Bottaa-Fridlund, Rene Gerolami, David Douglas, Dinesh Ranjan, Dominik Faust, Joerg Trojan, Edward Gane, Erica Villa, Modentina Boarino, Etienne Sokal, Peter Starkel, Ferruccio Bonino, Brunetto Maurizio, Fred Gordon, JoAnne Pratt, Frieder Berr, Ingolf Schiefke, Geoff McCaughan, Simone Strasser, Geoffrey Dusheiko, Georges Philipp Pageaux, Dominique Larrey, Giuseppe Pastore, Teresa Santantonio, Graeme Alexander, Tracy Woodall, Han Van Vlierberghe, Isabelle Colle, Hugh Harley, Jean Guggenheim, Aline Myx-Staccini, Jean Michel Metreau, Philippe Mavier, John Vierling, Tram Tran, Nigel Girgrah, Lisa Nyberg, Man Fung Yuen, Mang Ma, Manuel Delgado Balnco, Manuela Merli, Paola Tanzilli, Mario Angelico, Daniele Di Paolo, Mario Rizzetto, Alfredo Marzano, Pietro Lampertico, Martin Prieto, Marina Berenguer, Martina Felder, Martina Sterneck, Marc Willems, Michael Charlton, Timothy Gunneson, Michael Ritter, Michael Voight, Judy Swift, Mitchell Shiffman, Nicholas Tassopoulos, Isidoros Klissas, Nikolai Naourmov, Patrick Chamouard, Patrick Marcellin, Francois Durand, Peter Angus, Connelly Nathan, Pierluigi Toniutto, Elisabetta Fumo, Pietro Andreone, Carmela Cursaro, Rafael Barcena, Fernando Garcia Hoz, Reinhard Zachoval, Maria Christina, Robert Auke De Man, Herold Metselaar

Research output: Contribution to journalArticlepeer-review

Abstract

Wait-listed (n = 226) or post-liver transplantation (n = 241) chronic hepatitis B (CHB) patients with lamivudine-resistant hepatitis B virus (HBV) were treated with adefovir dipivoxil for a median of 39 and 99 weeks, respectively. Among wait-listed patients, serum HBV DNA levels became undetectable (

Original languageEnglish
Pages (from-to)349-360
Number of pages12
JournalLiver Transplantation
Volume13
Issue number3
DOIs
Publication statusPublished - Mar 2007

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Fingerprint Dive into the research topics of 'Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: Final long-term results'. Together they form a unique fingerprint.

Cite this